Shutterstock.com_1714981606/Nadya So

12 August 2025Reinsurance

Life insurance applicants increasingly using longevity drugs, warns Swiss Re

Repurposed drugs used for longevity are gaining popularity, according to global reinsurance group Swiss Re, prompting it to introduce guidance for underwriters on how to assess life insurance applicants who show signs of their use.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Swiss Re centralises strategic broker engagement across group

26 June 2026 Creates new broker management unit with veteran lead.

Exclusive: I-RE bets on captive gap in ‘overlooked’ US mid-market

25 June 2026 Andy Jeckells says the captive market has evolved to the point where brokers can no longer afford to ignore this segment.

Hannover Re finds a new way to fund favourite insurtech cedant

25 June 2026 A $250m structure pushes Hannover Re well outside of reinsurance.

More articles

Acrisure vs Epic: 5 resignations, 2 lawsuits, 1 intense morning

Hidden gem: US surplus lines shine when it comes to casualty & finance

US cyber price cuts eating away at growth potential: AM Best

Scor ordered to pay Covéa $488m compensation over retrocession treaties

Cyber losses move internal as insurers tie recovery to controls

Ardonagh continues digital, data investment with technology platform launch

False confidence tops cyber risk as Asia SME insurance barrier: Peak Re

Swiss Re centralises strategic broker engagement across group

Copyright © intelligentinsurer.com 2024 | Headless Content Management with Blaze